GE HealthCare × icometrix
GE HealthCare announced it entered into an agreement to acquire icometrix, a developer of AI-powered brain imaging analysis software. [33, 36] The financial terms of the deal were not disclosed. [35] The acquisition is intended to integrate icometrix's AI tools, including the FDA-cleared 'icobrain aria' for detecting side effects of Alzheimer's therapies, directly into GE HealthCare's MRI systems and imaging portfolio. [33, 38]
The asset
The icobrain platform, an AI-powered set of software solutions for the quantitative analysis of brain MRI scans for neurological disorders like Alzheimer's disease, multiple sclerosis, and epilepsy. [33, 35]
The record
- Seller status
- Going concern
- Sector
- medical imaging AI software
- Modalities
- images
- Jurisdiction
- US/Belgium
What it means if you hold data
This deal strengthens GE HealthCare's position in precision neurology by embedding AI-driven data analysis directly into the clinical workflow for managing complex neurological conditions. [35] It addresses the growing demand for quantitative monitoring of patients undergoing new anti-amyloid Alzheimer's treatments, turning raw imaging data into actionable clinical insights. [33, 38]
Sources
- gehealthcare.com — https://www.gehealthcare.com/about/newsroom/press-releases/ge-healthcare-announces-intent-to-acquire-icometrix-to-strengthen-neurology-portfolio-with-brain-mri-assessment-solutions
- hitconsultant.net — https://hitconsultant.net/2025/09/12/ge-healthcare-to-acquire-icometrix-to-advance-neurology-with-ai/